Gene · 1613
NIH grants1,435
NIH grants whose papers are about the gene, through NIH's grant-paper links.
341 to 360 of 1,435
Download this page as JSON| Grant | Title | DAPK3 papers | Newest fiscal year |
|---|---|---|---|
| R24ES028531 | Follow-up and Maintenance of the Newborn Epigenetics STudy (NEST) Cohort | 1 | 2022 |
| T32CA117846 | Pathways to Cancer Therapeutics | 1 | 2022 |
| T32GM007388 | Predoctoral Training in Genetics and Molecular Biology | 1 | 2022 |
| T32GM080189 | The Chemistry-Biology Interface Program at Johns Hopkins University | 1 | 2022 |
| T32HL069766 | Vascular Biology Training Grant | 1 | 2022 |
| U01AG046139 | A Systems Approach to Targeting Innate Immunity in AD | 1 | 2022 |
| U01AG061357 | AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers | 1 | 2022 |
| U01CA231844 | Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer | 1 | 2022 |
| U01DE028227 | Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers | 1 | 2022 |
| U01NS041588 | VCID and Stroke in a Bi-racial National Cohort | 1 | 2022 |
| U54AG062333 | Sex and Age Differences in Immunity to Influenza (SADII) | 1 | 2022 |
| U54CA225088 | Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs | 1 | 2022 |
| U54CA232568 | Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers | 1 | 2022 |
| U54CA233223 | THE RNA HELICASE EIF4A IS A THERAPEUTIC VULNERABILITY IN TRIPLE-NEGATIVE BREAST CANCER | 1 | 2022 |
| R01AG057339 | Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration | 2 | 2021 |
| R01NS102337 | Ferroportin and APP: Regulation of Iron Trafficking at the Blood-Brain Barrier | 2 | 2021 |
| F30CA228314 | Phosphorylation of ASCL1 to disrupt oncogenic activity in SCLC | 1 | 2021 |
| F31ES030278 | Investigating the Developmental Mechanisms of TCDD-Induced Reproductive Dysregulation | 1 | 2021 |
| IK6BX003780 | BLR&D Research Career Scientist Award Application | 1 | 2021 |
| K01OD019912 | The role of zinc transporters and dietary zinc in calcium oxalate urolithiasis | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1613/grants?page=18